Abstract
Background: Insulin resistance can occur even in non-obese individuals, particularly among Asian populations, where visceral adiposity contributes to metabolic risk. The triglyceride-glucose (TyG) index has emerged as a simple and reliable surrogate marker of insulin resistance. In Vietnam, evidence linking the TyG index to metabolic abnormalities in this group is still scarce.
Objective: To describe the metabolic characteristics of non-obese adults with prediabetes in Central Vietnam and to examine the associations between the TyG index and selected anthropometric and lipid-related risk factors.
Methods: A cross-sectional study of 104 non-obese adults (BMI < 25 kg/m²), aged 20 - 65 years, with newly diagnosed prediabetes (ADA 2022 criteria) consecutively enrolled from community health centers in Quang Binh, Hue, and Da Nang City (October 2022 to October 2025). Anthropometric, glycaemic, and lipid parameters were assessed. An elevated TyG index (≥ 8.5) was used as a surrogate marker of insulin resistance. Pearson correlation and multiple linear regression were performed; triglycerides were excluded from the multivariable model as a direct mathematical component of the TyG formula.
Results: Mean age 50.56 ± 9.68 years; mean BMI of 23.39 ± 1.88 kg/m². Central adiposity (WHtR ≥ 0.5) was present in 67.3%, and 76.0% exhibited elevated TyG index. Dyslipidaemia was prevalent: TC ≥ 5.2 mmol/L in 55.8%, hypertriglyceridaemia in 42.3%, elevated non-HDL-C in 73.1%. TyG correlated significantly with TC/HDL-C (r = 0.532), non-HDL-C (r = 0.479), TC (r = 0.395), and WC (r = 0.243). In multivariable regression, independent predictors of TyG were: TC (β = 0.463, p < 0.001), HDL-C (β = -0.303, p = 0.001), female sex (β = -0.287, p = 0.002), and fasting plasma glucose (β = 0.255, p = 0.002); adjusted R² = 0.371, F(8,95) = 8.589, p < 0.001.
Conclusions: In non-obese Vietnamese adults with prediabetes, the TyG index was significantly associated with central adiposity and atherogenic dyslipidaemia, with total cholesterol emerging as its strongest independent predictor. TyG may serve as a practical surrogate marker for cardiometabolic risk assessment in resource-limited primary care settings. Further prospective studies are needed to confirm these findings and establish clinical utility.
| Published | 2026-08-25 | |
| Fulltext |
|
|
| Language |
|
|
| Issue | Vol. 16 No. 04 (2026) | |
| Section | Original Articles | |
| DOI | 10.34071/jmp.2026.4.901 | |
| Keywords | prediabetes, TyG index, non-obese, Asian Lean Prediabetes, Visceral Fat |

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2026 Hue Journal of Medicine and Pharmacy
Rhee EJ. Diabetes in Asians. Endocrinol Metab. 2015;30(3):263-269.
Stefan N, Schick F, Häring HU. Causes, characteristics, and consequences of metabolically unhealthy normal weight in humans. Cell Metab; 2017 Aug 1;26(2):292-300.
Pluta W, Dudzińska W, Lubkowska A. Metabolic Obesity in People with Normal Body Weight (MONW)-Review of Diagnostic Criteria. Int J Environ Res Public Health. 2022 Jan 6;19(2):624. doi: 10.3390/ijerph19020624.
Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008 Sep;6(4):299-304.
Park HM, Lee HS, Lee YJ, Lee JH. The triglyceride-glucose index is a more powerful surrogate marker for predicting the prevalence and incidence of type 2 diabetes mellitus than the homeostatic model assessment of insulin resistance. Diabetes Metab J. 2021 Oct;45(5):733-746.
Pham T, Bui L, Giovannucci E, Hoang M, Tran B, Chavarro JE, et al. Prevalence of obesity and abdominal obesity and their association with metabolic-related conditions in Vietnamese adults: an analysis of Vietnam STEPS survey 2009 and 2015. Lancet Reg Health West Pac. 2023;39:100859.
Dang AK, Thi Le LT, Pham NM, Nguyen DQ, Thi Nguyen HT, Dang SC, et al. An upward trend of dyslipidemia among adult population in Vietnam: Evidence from a systematic review and meta-analysis. Diabetes Metab Syndr Clin Res Rev. 2025; doi: 10.1016/j.dsx.2024.103171.
WHO Consultation on Obesity & World Health Organization. Obesity : preventing and managing the global epidemic: report of a WHO consultation. World Health Organization; 2000.
American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2022. Diabetes Care; 2022 Jan 1;45(Supplement_1):S17-S38.
International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. Brussels: IDF; 2006.
Ashwell M, Gibson S. A proposal for a primary screening tool: ‘Keep your waist circumference to less than half your height’. BMC Med. 2014;12:207. DOI: 10.1186/s12916-014-0207-1
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486–2497. doi: 10.1001/jama.285.19.2486.
Lim S, Meigs JB. Links between ectopic fat and vascular disease in humans. Arterioscler Thromb Vasc Biol; 2014 Aug;34(8):1820-6.







